🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Sagimet Biosciences Inc.

SGMT Healthcare
$10.2 +$0.35 (3.55%)
Market Cap: $727.95 M
Gurus Holding
3
Popularity Rank
#3165
% of Shares Held
0.20%
Net Activity (Q3 2026)
-$2.02 M

Guru Ownership Trend

Guru Analysis for Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. (SGMT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.45 M.

Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.02 M net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 74.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$517,594
Total Buy Value
New Buys 2
Additions 0
-$2.54 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Sagimet Biosciences Inc. (SGMT)

Major holders include Renaissance Technologies (RenTech) ($886,236), Steven Cohen ($352,015), Cliff Asness ($165,579). According to the latest reported data, 3 tracked investment managers collectively hold approximately 142,088 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.02 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited SGMT. The total reported sell value was $2.54 M.

Yes, 2 managers opened new positions in SGMT, and 0 increased their existing holdings. The total reported buy value was $517,594.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -74.1% 89,700 $886,236 Q3 2026
0.00% New Buy 35,629 $352,015 Q3 2026
0.00% New Buy 16,759 $165,579 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form